These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

431 related items for PubMed ID: 15536198

  • 1. Tumor necrosis factor promotes human T-cell development in nonobese diabetic/severe combined immunodeficient mice.
    Samira S, Ferrand C, Peled A, Nagler A, Tovbin Y, Ben-Hur H, Taylor N, Globerson A, Lapidot T.
    Stem Cells; 2004; 22(6):1085-100. PubMed ID: 15536198
    [Abstract] [Full Text] [Related]

  • 2. Co-expression of CD8 alpha in CD4+ T cell receptor alpha beta + T cells migrating into the murine small intestine epithelial layer.
    Reimann J, Rudolphi A.
    Eur J Immunol; 1995 Jun; 25(6):1580-8. PubMed ID: 7614985
    [Abstract] [Full Text] [Related]

  • 3. Hematopoietic repopulating ability of cord blood CD34(+) cells in NOD/Shi-scid mice.
    Ueda T, Yoshino H, Kobayashi K, Kawahata M, Ebihara Y, Ito M, Asano S, Nakahata T, Tsuji K.
    Stem Cells; 2000 Jun; 18(3):204-13. PubMed ID: 10840074
    [Abstract] [Full Text] [Related]

  • 4. Compartmentalization of allogeneic T-cell responses in the bone marrow and spleen of humanized NOD/SCID mice containing activated human resident myeloid dendritic cells.
    Vuckovic S, Abdul Wahid FS, Rice A, Kato M, Khalil D, Rodwell R, Hart DN.
    Exp Hematol; 2008 Nov; 36(11):1496-506. PubMed ID: 18715688
    [Abstract] [Full Text] [Related]

  • 5. Human hematopoietic stem/progenitor cells generate CD5+ B lymphoid cells in NOD/SCID mice.
    Novelli EM, Ramírez M, Leung W, Civin CI.
    Stem Cells; 1999 Nov; 17(5):242-52. PubMed ID: 10527459
    [Abstract] [Full Text] [Related]

  • 6. Clinically relevant expansion of hematopoietic stem cells with conserved function in a single-use, closed-system bioprocess.
    Madlambayan GJ, Rogers I, Purpura KA, Ito C, Yu M, Kirouac D, Casper RF, Zandstra PW.
    Biol Blood Marrow Transplant; 2006 Oct; 12(10):1020-30. PubMed ID: 17084368
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Clonotypic myeloma cells able to xenograft myeloma to nonobese diabetic severe combined immunodeficient mice copurify with CD34 (+) hematopoietic progenitors.
    Pilarski LM, Belch AR.
    Clin Cancer Res; 2002 Oct; 8(10):3198-204. PubMed ID: 12374689
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Establishment of an xenogeneic acute graft-versus-host disease model in NOD/SCID mice by engraftment of G-CSF mobilized human mononuclear cells].
    Gao L, Wang JM, Xie LN, Zhou H, Qiu HY.
    Zhonghua Xue Ye Xue Za Zhi; 2008 Feb; 29(2):87-91. PubMed ID: 18681307
    [Abstract] [Full Text] [Related]

  • 11. Ex vivo expansion does not alter the capacity of umbilical cord blood CD34+ cells to generate functional T lymphocytes and dendritic cells.
    Kobari L, Giarratana MC, Gluckman JC, Douay L, Rosenzwajg M.
    Stem Cells; 2006 Sep; 24(9):2150-7. PubMed ID: 16946001
    [Abstract] [Full Text] [Related]

  • 12. Interleukin-3 promotes proliferation and differentiation of human hematopoietic stem cells but reduces their repopulation potential in NOD/SCID mice.
    Nitsche A, Junghahn I, Thulke S, Aumann J, Radonić A, Fichtner I, Siegert W.
    Stem Cells; 2003 Sep; 21(2):236-44. PubMed ID: 12634420
    [Abstract] [Full Text] [Related]

  • 13. Mobilized human CD34+ hematopoietic stem cells enhance tumor growth in a nonobese diabetic/severe combined immunodeficient mouse model of human non-Hodgkin's lymphoma.
    de Bont ES, Guikema JE, Scherpen F, Meeuwsen T, Kamps WA, Vellenga E, Bos NA.
    Cancer Res; 2001 Oct 15; 61(20):7654-9. PubMed ID: 11606408
    [Abstract] [Full Text] [Related]

  • 14. Engraftment of human T-cell acute lymphoblastic leukemia in immunodeficient NOD/SCID mice which have been preconditioned by injection of human cord blood.
    Dialynas DP, Shao L, Billman GF, Yu J.
    Stem Cells; 2001 Oct 15; 19(5):443-52. PubMed ID: 11553853
    [Abstract] [Full Text] [Related]

  • 15. CD45 congenic bone marrow transplantation: evidence for T cell-mediated immunity.
    Xu H, Exner BG, Chilton PM, Schanie C, Ildstad ST.
    Stem Cells; 2004 Oct 15; 22(6):1039-48. PubMed ID: 15536194
    [Abstract] [Full Text] [Related]

  • 16. Immunohematologic reconstitution in pediatric patients after T cell-depleted HLA-haploidentical stem cell transplantation for thalassemia.
    Isgrò A, Marziali M, Sodani P, Gaziev J, Erer B, Polchi P, Paciaroni K, Roveda A, De Angelis G, Gallucci C, Alfieri C, Simone MD, Zinno F, Isacchi G, Adorno G, Lanti A, Leti W, Aiuti F, Fraboni D, Andreani M, Lucarelli G.
    Biol Blood Marrow Transplant; 2010 Nov 15; 16(11):1557-66. PubMed ID: 20546907
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Selection of stem cells by using antibodies that target different CD34 epitopes yields different patterns of T-cell differentiation.
    Otto M, Chen X, Martin WJ, Leung W, Knowles J, Holladay M, Houston J, Handgretinger R, Barfield RC.
    Stem Cells; 2007 Feb 15; 25(2):537-42. PubMed ID: 17023516
    [Abstract] [Full Text] [Related]

  • 20. Long-term human CD34+ stem cell-engrafted nonobese diabetic/SCID/IL-2R gamma(null) mice show impaired CD8+ T cell maintenance and a functional arrest of immature NK cells.
    André MC, Erbacher A, Gille C, Schmauke V, Goecke B, Hohberger A, Mang P, Wilhelm A, Mueller I, Herr W, Lang P, Handgretinger R, Hartwig UF.
    J Immunol; 2010 Sep 01; 185(5):2710-20. PubMed ID: 20668220
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.